chondroitin-sulfates has been researched along with Brain-Infarction* in 1 studies
1 other study(ies) available for chondroitin-sulfates and Brain-Infarction
Article | Year |
---|---|
Growth-associated gene expression after stroke: evidence for a growth-promoting region in peri-infarct cortex.
Stroke induces axonal sprouting in peri-infarct cortex. A set of growth-associated genes important in axonal sprouting in peripheral nervous system regeneration and cortical development has recently been defined. The expression profiles of these growth-associated genes were defined during the post-stroke axonal sprouting response using a model of stroke in barrel field cortex. Stroke induces sequential waves of neuronal growth-promoting genes during the sprouting response: an early expression peak (SPRR1), a mid expression peak (p21, Ta1 tubulin, L1, MARCKS), a late peak (SCG10, SCLIP), and an early/sustained pattern (GAP43, CAP23, c-jun). These expression peaks correspond to specific time points in the sprouting response. The expression of the growth-inhibiting chondroitin sulfate proteoglycans aggrecan, brevican, versican, and phosphacan are induced late in the sprouting process; except neurocan, which is increased during the peak of the growth-promoting gene expression. The developmentally associated growth inhibitors ephrin-A5, ephB1, semaphorin IIIa, and neuropilin 1 are also induced in the early phases of the sprouting response. At the cellular level, chondroitin sulfate proteoglycans, in the form of peri-neuronal nets, are reduced in the region of axonal sprouting, during the peak of growth-promoting gene expression. These results identify a unique profile of growth-promoting gene expression in adult cortex after stroke, the inhibitory molecules that are present during the sprouting response, and a region in which growth-promoting genes are increased, growth-inhibitory proteins are diminished and axonal sprouting occurs. This region may be a growth-promoting zone after stroke. Topics: Aggrecans; Animals; Brain Infarction; Cerebral Cortex; Chondroitin Sulfate Proteoglycans; Chondroitin Sulfates; Disease Models, Animal; Extracellular Matrix Proteins; Gene Expression; Gene Expression Regulation; Immunohistochemistry; In Situ Hybridization; Lectins, C-Type; Male; Nerve Growth Factors; Nerve Tissue Proteins; Proteoglycans; Rats; Rats, Inbred F344; Receptor-Like Protein Tyrosine Phosphatases, Class 5; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Stroke; Time Factors; Versicans | 2005 |